Also found in: Medical, Wikipedia.


A selective estrogen receptor modulator, C28H27NO4S, used in the form of its hydrochloride primarily to treat and prevent osteoporosis in postmenopausal women.

[ral-, of unknown origin + (eth)oxy + alteration and blend of phen(yl) and -ene.]


(rəˈlɒk səˌfin)
a drug, C28H27NO4S, prescribed primarily to prevent postmenopausal osteoporosis.


n raloxifeno
References in periodicals archive ?
A research team consisting of researchers from Arabian Gulf University (AGU), Japan and the United States discovered the possibility of using the drug raloxifene, used in the treatment of osteoporosis in women, to treat inflammatory bowel disease (IBD).
M2 EQUITYBITES-November 14, 2016-Dr Reddy's Laboratories unveils Raloxifene HCl Tablets, USP in the US market
M2 PHARMA-November 14, 2016-Dr Reddy's Laboratories unveils Raloxifene HCl Tablets, USP in the US market
The osteoporosis drug raloxifene (Evista) failed to improve memory and thinking skills in women with Alzheimer's disease (AD), according to a study published online Nov.
Raloxifene (raloxifene hydrochloride), a non-hormone drug against bone resorption, belongs to the second generation of selective estrogen receptor modulator (SERMs).
When tested in normal human mammary tissue explant cultures, ospemifene was also found to have antiestrogenic, growth inhibitory effects, similar to raloxifene and tamoxifen.
Prevention is an important tool in the fight against breast cancer, and two drugs--tamoxifen (Nolvadex) and raloxifene (Evista)--are currently first-line weapons in that war.
24, 2014, 1 year after the USPSTF first issued a "B" rating also, for use of the selective estrogen receptor modulators, tamoxifen, or raloxifene (Evista) for women at high risk for breast cancer and low risk for side effects.
Currently, tamoxifen and raloxifene are the only Food and Drug Administration--approved drugs for breast cancer prevention in high-risk women.
1]) : Amount of drug was based on their weight, they received 30 mg raloxifene tablet dissolved in 1 ml of distilled water.
The drug, either in the form of tamoxifen or raloxifene, could help more than 488,000 women in England and Wales dramatically slash their risk of breast cancer.
The National Institute of Health and Clinical Excellence (Nice) has launched a draft consultation to see whether drugs tamoxifen or raloxifene should be offered to high-risk post-menopausal women in England and Wales.